Serum N1-methylnicotinamide is associated with obesity and diabetes in Chinese

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages 3112-3117

  Liu, Ming ^a,b   Li, Lihua ^c   Chu, Jihong ^a   Zhu, Boyu ^a   Zhang, Qingtao ^c   Yin, Xueyan ^c   Jiang, Weimin ^a   Dai, Guoliang ^a   Ju, Wenzheng ^a   Wang, Zhenxing ^a   Yang, Qin ^b   Fang, Zhuyuan ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DALI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLNICOTINAMIDE; ALANINE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; N(1)-METHYLNICOTINAMIDE; NICOTINAMIDE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HIP CIRCUMFERENCE; HUMAN; LIQUID CHROMATOGRAPHY; LIVER FUNCTION; MALE; MASS SPECTROMETRY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ANALOGS AND DERIVATIVES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; OVERWEIGHT; STATISTICS AND NUMERICAL DATA;

MUS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NIACINAMIDE; OBESITY; OVERWEIGHT;

EID: 84939162510     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1732     Document Type: Article

References (30)

1. Hruby A, Hu FB. The epidemiology of obesity: a big picture [published online ahead of print December 4, 2014]. Pharmacoeconomics.
2. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249-1257.
3. Hill JO, Wyatt HR, Peters JC. Energy balance and obesity. Circulation. 2012;126:126-132.
4. Drong AW, Lindgren CM, McCarthy MI. The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther. 2012;92:707-715.
5. Teperino R, Schoonjans K, Auwerx J. Histone methyl transferases and demethylases; can they link metabolism and transcription? Cell Metab. 2010;12:321-327.
6. Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508:258-262.
7. Aksoy S, Szumlanski CL, Weinshilboum RM. Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. J Biol Chem. 1994;269:14835-14840.
8. Riederer M, Erwa W, Zimmermann R, Frank S, Zechner R. Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. Atherosclerosis. 2009;204:412-417.
9. Kannt A, Pfenninger A, Teichert L, et al. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia. 2015;58:799-808.
10. Szafarz M, Lomnicka M, Sternak M, Chlopicki S, Szymura-Oleksiak J. Simultaneous determination of nicotinic acid and its four metabolites in rat plasma using high performance liquid chromatography with tandem mass spectrometric detection (LC/MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:895-902.
11. Salek RM, Maguire ML, Bentley E, et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007;29:99-108.
12. Li L, Yin X, Yao C, Zhu X, Wu X. Vitamin D, parathyroid hormone and their associations with hypertension in a Chinese population. PLoS One. 2012;7:e43344.
13. Li LH, Yin XY, Yao CY, Zhu XC, Wu XH. Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese. Endocrine. 2013;44:465-472.
14. Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults - study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83-96.
15. Zhou SS, Li D, Sun WP, et al. Nicotinamide overload may play a role in the development of type 2 diabetes. World J Gastroenterol. 2009;15:5674-5684.
16. Du T, Sun X, Yin P, Huo R, Ni C, Yu X. Increasing trends in central obesity among Chinese adults with normal body mass index, 1993-2009. BMC Public Health. 2013;13:327.
17. Fan JG, Zhu J, Li XJ, et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol. 2005;20:1825-1832.
18. Li H, Wang YJ, Tan K, et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat Dis Int. 2009;8:377-382.
19. Zhou YJ, Li YY, Nie YQ, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007;13:6419-6424.
20. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395.
21. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124-131.
22. Liao D, Tan H, Hui R, et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Circ Res. 2006;99:598-606.
23. Shai I, Stampfer MJ, Ma J, et al. Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis. 2004;177:375-381.
24. Marcus J, Sarnak MJ, Menon V. Homocysteine lowering and cardiovascular disease risk: lost in translation. Can J Cardiol. 2007;23:707-710.
25. Mateuszuk Ł, Khomich TI, Słominska E, et al. Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis. Pharmacol Rep. 2009;61:76-85.
26. Peng Y, Sartini D, Pozzi V, Wilk D, Emanuelli M, Yee VC. Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry. 2011;50:7800-7808.
27. +: an old metabolite controlling new metabolic signaling pathways. Endocr Rev. 2010;31:194-223.
28. Kavanagh K, Jones KL, Sawyer J, et al. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity (Silver Spring). 2007;15:1675-1684.
29. Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol. 2005;161:672-679.
30. Malik VS, Pan A, Willett WC, Hu FB. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr. 2013;98:1084-1102.